Autopsy report · NCT00474110
Ketamine and Hydromorphone for Patient Controlled Pain Relief in Children's Mucositis
Cause of deathSlow enrollment
“Clinical practice had changed between time of initial protocol development and subject recruitment. We were not able to find eligible patients.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 3
- Sponsor
- University of British Columbia
- Sponsor type
- University, hospital or other
- Conditions
- Mucositis
- Interventions
- Ketamine & hydromorphone
- Participants
- 0
- Sites
- 1
- Countries
- Canada
Trials that died the same way
- Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults
“No more patients complying the selection criteria were available for recruitment” - Dolores One: Maximizing Functional Communication for Adults
“change in clinical practice that led to ability to recruit subjects” - Vitamin D Levels In Patients Who Has Normal to Grade 2 Knee Arthroscopy Changes
“Lack of patients with recruitment criteria” - Dietary Guidelines for Americans-Ultra Processed Study
“Change in administrative priorities. Protocol has been published, but recruitment never started.” - Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
“Study stopped due to difficulties in patient recruitment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.